Status:
COMPLETED
Studying Normal Breast Tissue and Cancer Risk
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Breast Neoplasms
Neoplasms by Site
Eligibility:
FEMALE
11-120 years
Brief Summary
Breast cancer is the most common cancer among women in the United States. Breast cancer research has been hampered by the difficulty in collecting normal breast tissue. In this study, researchers will...
Detailed Description
This pilot project, funded by a Breast Cancer Faculty Infrastructure Award, would determine the feasibility of obtaining samples of normal breast tissue from organ donors and collecting risk factor da...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- The study will enroll girls or women aged 11 years or older.
- EXCLUSION CRITERIA
- Men are excluded.
Exclusion
Key Trial Info
Start Date :
April 7 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2020
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00341692
Start Date
April 7 2003
End Date
April 28 2020
Last Update
April 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892